1. The authors failed to mention the duration of the study period. Was the study period a fixed amount of time for each subject (e.g., 96 hours of monitoring) or determined by the length of time pulse oximetry was required for therapeutic monitoring? If the latter, how was the discontinuance of therapeutic monitoring handled for data analysis purposes of the sensor longevity since including them in measures of central tendency, such as median or mean, could be misleading? The lack of detail on how sensor removal for therapeutic reasons was handled for data analysis purposes is a critical omission in this study, making interpretation of the data problematic. 2. Table 1 in the published paper indicates that sensor longevity was analyzed as median days, along with a standard deviation. Calculation of a median value does not include a standard deviation F is it possible that the data represent mean days rather than median? 3. What statistical tests were used to test the research hypotheses and similarity of subject characteristics from the two sites? 4. The results relating to the reason for changing of the sensors are confusing. For subjects in the Masimo group (N ¼ 56), there are 56 reasons for sensor changes. For subjects in the Nellcor group (N ¼ 65), there are only 40 reasons for sensor changes. Given that the longevity for sensor use was shorter in the Nellcor group, these numbers do not make sense since you would assume that the Nellcor subjects would have had to have more sensors used/subject than the Masimo group if the time for therapeutic monitoring for the two groups was similar. Is this discrepancy related to missing data? Or could it be possible that 25 of the Nellcor subjects did not require a change in sensor prior to therapeutic monitoring being discontinued? If missing data is the problem, why was it so high in the Nellcor group and not the Masimo group? If the reason for the discrepancy is that 25 Nellcor subjects had monitoring discontinued during the first sensor use, it would appear that fewer sensors were used per patient in the Nellcor group (40 additional sensors in 65 subjects) than in the Masimo group (56 additional sensors in 56 subjects). This information would lead one to a very different interpretation of the results than those presented in the paper. 5. From the readers vantage point, it is a shame that the reasons for sensor change were not presented as a percentage of the sample, rather than raw numbers. Given the unequal number of subjects in each group, standardizing the numbers with a percentage would have been more informative (see Table 1 below).
Thank you for consideration of these issues. Studies such as these can have important implications for clinical practice and it is crucial that the study methods and results be thoroughly described to allow for accurate interpretation of findings by the reader. The deficiencies in reporting detailed above are such that readers should be very hesitant to use the findings of this study to guide decisions on the most cost-effective type of sensor to use for therapeutic pulse oximetry monitoring. 
